Assignee profile:

SBI PHARMACEUTICALS CO., LTD.

City:

Tokyo

Country:

Japan

Published Applications:

44

Last publication date:

2023-06-22

Patent Grants:

42

Last grant date:

2023-12-26

Top Inventors for applications by SBI PHARMACEUTICALS CO., LTD.

These are the the leading inventors for applications assigned to SBI PHARMACEUTICALS CO., LTD.:

Recent patent applications by SBI PHARMACEUTICALS CO., LTD.

SBI PHARMACEUTICALS CO., LTD. based in Tokyo, JP has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-06-22 ✅ Patent 11,849,922 granted on 2023-12-26
US20230190085A1
Human necessities

Light source device

#2 | 2022-08-11 ✅ Patent 12,558,332 granted on 2026-02-24
US20220249417A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR ENHANCING ANTITUMOR EFFECT BY IMMUNE CHECKPOINT INHIBITOR

#3 | 2022-07-07 ✅ Patent 12,433,857 granted on 2025-10-07
US20220211646A1
Human necessities

CONJUGATE AND CANCER THERAPEUTIC AGENT

#4 | 2020-09-24 ✅ Patent 11,266,619 granted on 2022-03-08
US20200297674A1
Human necessities

Pharmaceutical composition for enhancing antitumor effect by immune checkpoint inhibitor

#5 | 2020-05-28 ✅ Patent 11,123,320 granted on 2021-09-21
US20200163917A1
Human necessities

Prophylactic or therapeutic agent for hyperaciive bladder

#6 | 2019-10-24 ✅ Patent 10,974,062 granted on 2021-04-13
US20190321653A1
Human necessities

Photoirradiation substrate

#7 | 2019-07-04 ✅ Patent 10,675,242 granted on 2020-06-09
US20190201336A1
Human necessities

Aqueous formulation containing 5-aminolevulinic acid or the like

#8 | 2018-05-10 ✅ Patent 11,421,204 granted on 2022-08-23
US20180127726A1
Chemistry; metallurgy

Method of removing pluripotent cells from culture

#9 | 2018-05-10
US20180125805A1
Human necessities

PROPHYLACTIC/THERAPEUTIC AGENT FOR VIRUS INFECTIONS WHICH COMPRISES ALA COMPOUND

#10 | 2017-06-08 ✅ Patent 9,962,350 granted on 2018-05-08
US20170157074A1
Human necessities

Agent for improving normal development rate of fertilized eggs

#11 | 2016-12-15
US20160361418A1
Human necessities

COMPOSITION FOR PREVENTION OR TREATMENT OF TREATMENT-RESISTANT CANCER

#12 | 2016-07-21 ✅ Patent 9,937,138 granted on 2018-04-10
US20160206582A1
Human necessities

Enhancer of survival of transplanted organ

#13 | 2016-06-30 ✅ Patent 9,901,558 granted on 2018-02-27
US20160184250A1
Human necessities

Enhancer of survival of transplanted organ

#14 | 2016-05-19 ✅ Patent 9,603,928 granted on 2017-03-28
US20160136274A1
Human necessities

Medicinal composition for promoting synthesis of protoporphyrin IX

#15 | 2016-03-24 ✅ Patent 10,022,345 granted on 2018-07-17
US20160081957A1
Human necessities

Agent for preventing and/or treating veisalgia

#16 | 2015-11-12 ✅ Patent 11,633,505 granted on 2023-04-25
US20150320888A1
Human necessities

Nuclear magnetic resonance diagnostic agent, and method for detecting or diagnosing state of cell, tissue or organ in subject using same

#17 | 2015-10-22 ✅ Patent 9,517,267 granted on 2016-12-13
US20150297720A1
Human necessities

Photodynamic diagnostic agent and photobleaching inhibitor

#18 | 2015-10-15 ✅ Patent 9,730,904 granted on 2017-08-15
US20150290159A1
Human necessities

Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative of 5-aminolevulinic acid as active ingredient

#19 | 2015-10-08 ✅ Patent 9,463,175 granted on 2016-10-11
US20150283102A1
Human necessities

Antimalarial drug which contains 5-aminolevulinic acid or derivative thereof as active ingredient

#20 | 2015-07-09 ✅ Patent 9,895,331 granted on 2018-02-20
US20150190356A1
Human necessities

Prophylactic and/or therapeutic agent for radiation damage

#21 | 2015-06-25 ✅ Patent 9,399,029 granted on 2016-07-26
US20150174090A1
Human necessities

Immune tolerance inducer

#22 | 2015-06-18 ✅ Patent 9,351,949 granted on 2016-05-31
US20150164838A1
Human necessities

Prophylactic/therapeutic agent for influenza virus infection

#23 | 2015-01-29 ✅ Patent 9,488,664 granted on 2016-11-08
US20150031013A1
Physics

Diagnostic agent for tumor

#24 | 2014-10-09 ✅ Patent 9,707,196 granted on 2017-07-18
US20140302173A1
Human necessities

Treatment agent and/or prophylactic agent for side effects of cancer drugs

#25 | 2014-09-25 ✅ Patent 9,539,225 granted on 2017-01-10
US20140288173A1
Human necessities

Anemia of cancer improving/prophylactic agent

#26 | 2014-09-25 ✅ Patent 9,469,598 granted on 2016-10-18
US20140288172A1
Chemistry; metallurgy

Erythropoietin production-promoting agent

#27 | 2014-09-11 ✅ Patent 9,475,755 granted on 2016-10-25
US20140256806A1
Chemistry; metallurgy

Prophylactic agent for chronic kidney disease

#28 | 2014-09-04 ✅ Patent 9,314,443 granted on 2016-04-19
US20140249217A1
Human necessities

Enhancer of survival of transplanted organ

#29 | 2014-07-03 ✅ Patent 9,550,073 granted on 2017-01-24
US20140188034A1
Human necessities

Therapeutic agent for allergic rhinitis

#30 | 2014-07-03 ✅ Patent 9,474,770 granted on 2016-10-25
US20140186464A1
Human necessities

Prophylactic agent and/or therapeutic agent for sepsis

#31 | 2014-05-08 ✅ Patent 9,345,904 granted on 2016-05-24
US20140128799A1
Human necessities

Photodynamic therapy using photosensitizing agent or 5-aminolevulinic acid

#32 | 2014-02-27 ✅ Patent 9,757,357 granted on 2017-09-12
US20140056817A1
Human necessities

Photodynamic therapy or diagnostic agent, using infrared-spectrum light

#33 | 2013-08-22 ✅ Patent 9,295,660 granted on 2016-03-29
US20130217913A1
Human necessities

Antimalarial drug comprising alaremycin or derivative thereof as active ingredient

#34 | 2013-06-20 ✅ Patent 9,012,502 granted on 2015-04-21
US20130158293A1
Chemistry; metallurgy

Cancer heat therapy-enhancing agent

#35 | 2013-05-02 ✅ Patent 9,089,530 granted on 2015-07-28
US20130108710A1
Human necessities

Antimalarial drug which contains 5-aminolevulinic acid or derivative thereof as active ingredient

#36 | 2013-04-18 ✅ Patent 9,772,286 granted on 2017-09-26
US20130095520A1
Physics

Method for detection of urothelial cancer

#37 | 2013-01-10 ✅ Patent 8,927,532 granted on 2015-01-06
US20130011337A1
Human necessities

Therapeutic agent and diagnostic agent for mitochondrial dysfunction brain diseases

#38 | 2012-10-11 ✅ Patent 9,743,836 granted on 2017-08-29
US20120259231A1
Human necessities

Excitation, detection, and projection system for visualizing target cancer tissue

#39 | 2011-08-11 ✅ Patent 9,095,165 granted on 2015-08-04
US20110196033A1
Human necessities

Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative of 5-aminolevulinic acid as active ingredient

#40 | 2011-03-17 ✅ Patent 8,563,605 granted on 2013-10-22
US20110065787A1
Human necessities

Therapeutic agent for male sterility

#41 | 2011-03-10 ✅ Patent 9,333,156 granted on 2016-05-10
US20110060042A1
Human necessities

External preparation for skin

#42 | 2011-02-10 ✅ Patent 8,999,296 granted on 2015-04-07
US20110033386A1
Human necessities

Method of detecting bladder cancer

#43 | 2008-05-08 ✅ Patent 9,340,490 granted on 2016-05-17
US20080108701A1
Chemistry; metallurgy

Diagnostic agent for tumor

#44 | 2008-01-31 ✅ Patent 8,790,712 granted on 2014-07-29
US20080026075A1
Human necessities

Constitutional function-improving agents

Also check out SBI Pharmaceuticals Co., Ltd.'s (Tokyo, Japan) applicant profile with 21 patent applications submitted.

AssigneeID:

3302 ⎘